Annual ROE
-32.21%
-27.07%-526.65%
31 December 2023
Summary:
BioNexus Gene Lab annual return on equity is currently -32.21%, with the most recent change of -27.07% (-526.65%) on 31 December 2023. During the last 3 years, it has fallen by -60.32% (-214.59%). BGLC annual ROE is now -214.59% below its all-time high of 28.11%, reached on 01 December 2020.BGLC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-9.89%
+15.06%+60.36%
30 September 2024
Summary:
BioNexus Gene Lab quarterly return on equity is currently -9.89%, with the most recent change of +15.06% (+60.36%) on 30 September 2024. Over the past year, it has increased by +33.94% (+77.44%). BGLC quarterly ROE is now -108.53% below its all-time high of 115.93%, reached on 01 September 2020.BGLC Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGLC ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -526.6% | +77.4% |
| 3 y3 years | -214.6% | -214.5% |
| 5 y5 years | -1951.2% | - |
BGLC ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -214.6% | at low | -190.8% | +77.4% |
| 5 y | 5 years | -214.6% | at low | -108.5% | +77.4% |
| alltime | all time | -214.6% | at low | -108.5% | +77.4% |
BioNexus Gene Lab ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -9.89%(-60.4%) |
| June 2024 | - | -24.95%(-22.8%) |
| Mar 2024 | - | -32.32%(-5.3%) |
| Dec 2023 | -32.21%(+526.7%) | -34.12%(-22.2%) |
| Sept 2023 | - | -43.83%(+405.0%) |
| June 2023 | - | -8.68%(+31.9%) |
| Mar 2023 | - | -6.58%(+26.5%) |
| Dec 2022 | -5.14%(-147.3%) | -5.20%(+227.0%) |
| Sept 2022 | - | -1.59%(-142.3%) |
| June 2022 | - | 3.76%(-38.9%) |
| Mar 2022 | - | 6.15% |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | 10.86%(-61.4%) | - |
| Dec 2021 | - | 10.89%(+26.0%) |
| Sept 2021 | - | 8.64%(-10.4%) |
| June 2021 | - | 9.64%(-13.0%) |
| Mar 2021 | - | 11.08%(-78.3%) |
| Dec 2020 | 28.11%(-250.8%) | 51.04%(-56.0%) |
| Sept 2020 | - | 115.93%(+31.4%) |
| June 2020 | - | 88.25%(+7.5%) |
| Mar 2020 | - | 82.09%(-473.8%) |
| Dec 2019 | -18.64%(-1171.3%) | -21.96% |
| Dec 2018 | 1.74% | - |
FAQ
- What is BioNexus Gene Lab annual return on equity?
- What is the all time high annual ROE for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual ROE year-on-year change?
- What is BioNexus Gene Lab quarterly return on equity?
- What is the all time high quarterly ROE for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly ROE year-on-year change?
What is BioNexus Gene Lab annual return on equity?
The current annual ROE of BGLC is -32.21%
What is the all time high annual ROE for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual return on equity is 28.11%
What is BioNexus Gene Lab annual ROE year-on-year change?
Over the past year, BGLC annual return on equity has changed by -27.07% (-526.65%)
What is BioNexus Gene Lab quarterly return on equity?
The current quarterly ROE of BGLC is -9.89%
What is the all time high quarterly ROE for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly return on equity is 115.93%
What is BioNexus Gene Lab quarterly ROE year-on-year change?
Over the past year, BGLC quarterly return on equity has changed by +33.94% (+77.44%)